Isoliquiritigenin Inhibits circ0030018 To Suppress Glioma Tumorigenesis via the miR-1236/HER2 Signaling Pathway

Researchers treated glioma cells with isoliquiritigenin (ISL), and circRNA expression levels were detected. Circ0030018 was found significantly downregulated by ISL. Therefore, they explored circ0030018 expression profiles and functions in glioma.